
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Medable Inc.and MRN announced a global alliance to bring shared capabilities to decentralized clinical trials. Medable will empower MRN’s home clinical trial specialists to conduct home and remote visits using Medable’s Trial-Fit Telemedicine. The app can be deployed in one week or less for use in existing trials. These capabilities are especially important for clinical trial continuity in spite of widespread shelter-in-place initiatives due to COVID-19.
For more information, click






